BioPharma Credit PLC (MUN:B3P)

Germany flag Germany · Delayed Price · Currency is EUR
0.795
0.00 (0.00%)
At close: Dec 1, 2025
Market Cap 904.29M
Revenue (ttm) 134.35M
Net Income (ttm) 110.62M
Shares Out n/a
EPS (ttm) 0.10
PE Ratio 8.17
Forward PE n/a
Dividend 0.07 (8.78%)
Ex-Dividend Date Feb 19, 2026
Volume 200
Average Volume 3,285
Open 0.775
Previous Close 0.795
Day's Range 0.755 - 0.795
52-Week Range 0.750 - 0.870
Beta n/a
RSI n/a
Earnings Date Mar 24, 2026

About BioPharma Credit

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom. [Read more]

Industry Unit Investment Trusts, Face-Amount Certificate Offices, and Closed-End Management Investment Offices
Founded 2016
Country United Kingdom
Stock Exchange Munich Stock Exchange
Ticker Symbol B3P
Full Company Profile

Financial Performance

In 2025, BioPharma Credit's revenue was $157.75 million, an increase of 5.14% compared to the previous year's $150.03 million. Earnings were $129.89 million, an increase of 6.31%.

Financial numbers in USD

News

There is no news available yet.